T80.A Non-ABO incompatibility reaction due to transfusion of blood or blood products

Name of the Condition

• Non-ABO incompatibility reaction due to transfusion of blood or blood products.

Summary

This condition describes adverse reactions resulting from transfusion of blood or blood products that are not due to ABO blood group incompatibility. These reactions occur when the recipient’s immune system responds to antigens in the transfused blood, leading to clinical manifestations that may vary in severity.

Causes

Non-ABO incompatibility reactions can arise from immune responses to minor blood group antigens, such as Rh, Kell, Duffy, or Kidd systems, or from antibodies against platelet or plasma proteins. These reactions may be triggered by prior sensitization through pregnancy, previous transfusions, or organ transplants.

Risk Factors

• Prior exposure to incompatible blood products
• History of multiple transfusions or pregnancies
• Underlying immune-mediated conditions
• Use of blood products with non-ABO antigen mismatches
• Lack of pre-transfusion antibody screening in high-risk patients

Symptoms

• Fever, chills, or rigors
• Skin reactions (rash, urticaria, or flushing)
• Respiratory distress (wheezing, shortness of breath)
• Hypotension or tachycardia
• Hemolysis (evidenced by dark urine or jaundice)
• Renal impairment or oliguria

Diagnosis

Diagnosis involves correlating clinical symptoms with transfusion history, performing direct antiglobulin testing (DAT) to detect antibodies, and identifying specific antigen-antibody incompatibilities. Blood cultures and crossmatching may help rule out other causes.

Treatment Options

Management focuses on discontinuing the transfusion, providing supportive care (e.g., fluids, antihistamines, or corticosteroids), and addressing complications like hemolysis or renal failure. Severe cases may require plasma exchange or dialysis.

Prognosis and Follow-Up

Most reactions are mild and resolve with prompt treatment. Severe cases, particularly those with hemolysis or organ involvement, may have prolonged recovery. Follow-up includes monitoring for delayed reactions and ensuring future transfusions use compatible blood.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Transfusion-related acute lung injury (TRALI)
• Severe hemolytic anemia
• Hypotensive shock

Lifestyle & Prevention

Prevention relies on thorough pre-transfusion testing, including antibody screening and crossmatching. Patients with known antibodies should receive antigen-negative blood. Educating staff on proper transfusion protocols reduces risk.

When to Seek Professional Help

Seek immediate medical attention if symptoms like fever, respiratory distress, or hypotension occur during or after a transfusion. Delayed reactions (e.g., jaundice or dark urine) within days of transfusion also warrant evaluation.

Tips for Medical Coders

Document the specific blood product transfused, the timing of the reaction, and any laboratory findings (e.g., DAT results) to support the diagnosis. Ensure the code T80.A is used only when the reaction is confirmed as non-ABO incompatibility and not attributed to other causes like infection or mechanical issues.